| scholarly article | Q13442814 |
| P50 | author | Charlene E Gamaldo | Q56550086 |
| Richard P Allen | Q59195273 | ||
| P2093 | author name string | Rachel E Salas | |
| P2860 | cites work | DO RESTLESS LEGS SYNDROME (RLS) AND PERIODIC LIMB MOVEMENTS OF SLEEP (PLMS) PLAY A ROLE IN NOCTURNAL HYPERTENSION AND INCREASED CARDIOVASCULAR RISK OF RENALLY IMPAIRED PATIENTS? | Q57987780 |
| Predictors of impulsivity and reward seeking behavior with dopamine agonists | Q80803959 | ||
| Is there a higher risk of restless legs syndrome in peripheral neuropathy? | Q82751072 | ||
| Iron-deficiency sensitizes mice to acute pain stimuli and formalin-induced nociception | Q84582751 | ||
| Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis | Q24657853 | ||
| CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome | Q32052254 | ||
| Restless legs syndrome prevalence and impact: REST general population study | Q34426489 | ||
| Restless legs syndrome: a clinical update | Q34581039 | ||
| A genetic risk factor for periodic limb movements in sleep | Q34651669 | ||
| Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions | Q34653028 | ||
| Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study | Q34901531 | ||
| Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey | Q34938065 | ||
| Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome | Q35573180 | ||
| Restless legs syndrome: a common disorder in patients with rheumatologic conditions | Q36989055 | ||
| Polysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health Study | Q37212652 | ||
| Restless legs syndrome: differential diagnosis and management with rotigotine. | Q37224602 | ||
| Rotigotine transdermal patch: in restless legs syndrome | Q37267580 | ||
| Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome | Q37319535 | ||
| Sleep disorders and quality of life in renal transplant recipients | Q37382164 | ||
| The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics"). | Q37403311 | ||
| The treatment of restless legs syndrome with intravenous iron dextran | Q40507768 | ||
| Augmentation of the restless legs syndrome with carbidopa/levodopa. | Q42555191 | ||
| A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist | Q43136975 | ||
| Compulsive habits in restless legs syndrome patients under dopaminergic treatment | Q43227754 | ||
| Iron deficiency decreases dopamine D1 and D2 receptors in rat brain | Q43709791 | ||
| High prevalence of Dopaminergic Premonitory Symptoms in migraine patients with Restless Legs Syndrome: a pathogenetic link? | Q45344874 | ||
| Iron deficiency alters the day-night variation in monoamine levels in mice | Q46054305 | ||
| Drug hoarding: a case of atypical dopamine dysregulation syndrome in a RLS patient | Q46169446 | ||
| PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome | Q46460102 | ||
| Augmentation in restless legs syndrome is associated with low ferritin | Q46962458 | ||
| Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: Prevalence and characteristics | Q47594040 | ||
| A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome | Q47888000 | ||
| Do restless legs syndrome (RLS) and periodic limb movements of sleep (PLMS) play a role in nocturnal hypertension and increased cardiovascular risk of renally impaired patients? | Q48389151 | ||
| A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome | Q48398969 | ||
| Cortical involvement in the sensory and motor symptoms of primary restless legs syndrome. | Q48401339 | ||
| Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study | Q48408868 | ||
| The importance of oral iron therapy in restless legs syndrome | Q48412982 | ||
| Quiescegenic nocturnal dyskinesia: A restless legs syndrome (RLS) variant or a new syndrome? | Q48426542 | ||
| Assessing health-related quality of life in patients with restless legs syndrome | Q48439615 | ||
| Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. | Q48454119 | ||
| Validation of the Hopkins telephone diagnostic interview for restless legs syndrome | Q48462007 | ||
| Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study | Q48591904 | ||
| Exploring the relationship between Parkinson disease and restless legs syndrome | Q48667603 | ||
| Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? | Q48793612 | ||
| Iron deficiency alters dopamine transporter functioning in rat striatum | Q51373799 | ||
| A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis | Q53773769 | ||
| P433 | issue | 4 | |
| P921 | main subject | restless legs syndrome | Q916280 |
| P304 | page(s) | 401-406 | |
| P577 | publication date | 2010-08-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Current Opinion in Neurology | Q15716647 |
| P1476 | title | Update in restless legs syndrome | |
| P478 | volume | 23 |
| Q36864880 | An emerging role for Cullin-3 mediated ubiquitination in sleep and circadian rhythm: insights from Drosophila. |
| Q35937981 | Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women |
| Q34346563 | Evaluation of temperament and character features as risk factors for depressive symptoms in patients with restless legs syndrome |
| Q35095084 | Ferritin overexpression in Drosophila glia leads to iron deposition in the optic lobes and late-onset behavioral defects |
| Q24619903 | Genetics of Sleep and Sleep Disorders |
| Q37125764 | Human L-ferritin deficiency is characterized by idiopathic generalized seizures and atypical restless leg syndrome. |
| Q33860305 | Iron homeostasis in peripheral nervous system, still a black box? |
| Q54245394 | Management of restless legs syndrome in chronic liver disease: A challenge for the correct diagnosis and therapy |
| Q55178865 | Non-headache symptoms in migraine patients. |
| Q96954019 | Prevalence and Clinical Characteristics of the Restless Legs Syndrome (RLS) in Patients Diagnosed with Attention-Deficit Hyperactivity Disorder (ADHD) in Antioquia |
| Q30369942 | Prevalence of restless legs syndrome in North American and Western European populations: a systematic review |
| Q36379987 | Prospective Study of Restless Legs Syndrome and Risk of Depression in Women |
| Q84702116 | Restless Legs Syndrome in Behçet's Disease |
| Q36254524 | Restless Legs Syndrome in Multiple Myeloma Patients |
| Q37103449 | Restless leg syndrome in different types of demyelinating neuropathies: a single-center pilot study |
| Q40011231 | Restless legs syndrome in Chinese elderly people of an urban suburb in Shanghai: A community-based survey |
| Q34228792 | Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment |
| Q64928536 | Serum Ferritin Levels in Parkinson's Disease Patients with and without Restless Legs Syndrome. |
| Q37929127 | Sleep disturbance and neurological disease |
| Q37935163 | Sleep-Related Movement Disorders |
| Q48302181 | The prevalence of restless legs syndrome in adult Saudis attending primary health care |
| Q48249232 | Treatment for Restless Legs Syndrome Secondary to Chronic Liver Disease: A Case Report |
| Q27024585 | Treatment of restless legs syndrome |
Search more.